Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Potent and selective DAT ligand identified by RTI and Emory University

Jan. 22, 1999

Novel pure mu/kappa-opioid receptor antagonist as a lead in the field of drug abuse therapy

Jan. 20, 1999

Orphan drug for iron overload offered for licensing by Biomedical Frontiers

Jan. 18, 1999

Generic smoking cessation aid receives tentative FDA approval

Jan. 13, 1999

Novel cocaine analogues with promise in the treatment of cocaine addiction or overdose

Jan. 8, 1999

FDA approves OTC status for Elan's nicotine patch

Jan. 7, 1999

Selective inhibitor of neuronal dopamine transporter developed by U.S. university team

Jan. 4, 1999

Lilly develops novel 5-HT1A/5-HT1D antagonists for smoking cessation and CNS disorders

Dec. 23, 1998

SB launches smoking cessation line in European markets

Dec. 1, 1998

U.S. university researchers claim cocaine analogues for drug addiction, PD and depression

Nov. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...